Dr Gurvinder Singh is an expert in the field of Medical Oncology and practices evidence-based medicine, with focus on getting the best outcomes in cancer care. He is well experienced in managing all solid malignancies and hematological malignancies with a special interest in immunotherapy and targeted therapiy, chemotherapy, hormone therapy, precision oncology and individualised care.

​

Dr. Gurvinder completed his MBBS from University College of Medical Sciences, Delhi, MD (Internal Medicine) from Dr. SN Medical College, Jodhpur and DM (Medical Oncology) from Tata Memorial Hospital, Mumbai. Prior to his association with Cancer Centers of America, Dr. Gurvinder was associated with HBCH, Sangrur (A unit of Tata Memorial Hospital, Mumbai) as Assistant Professor in Department of Medical Oncology.

 

A gold medalist in MBBS, he is the recipient of the Certificate for the Best Resident during Swine Flu pandemic in 2015. He has also been awarded the first prize in the 5th Annual Conference of Research Society for the Study of Diabetes in Rajasthan Chapter. He is the first author on Serum Creatine Kinase, a marker of severity in organophosphorus poisoning cases in Indian Journal of applied research 6th June, 2017, Volume 7, Issue 6.